Individuals with high-risk hereditary cancer conditions such as Lynch Syndrome, or with other pathogenic variants indicating medium to low lifetime risk of developing breast cancers such as those with alterations in the PALB2 gene, may experience similar difficulties in accessing the appropriate healthcare in tiered systems. This evidence concerns the gene PALB2 and hereditary cancer.